Molecular designs of glucose-responsive and glucose-cleavable insulin analogues
AssigneeThe Trustees of Indiana University
InventorsMichael A. WEISS, Balamurugan DHAYALAN, Mark A. JAROSINSKI
Life of this patent
Estimating the term…
Abstract
A two-chain insulin analogue is provided containing (a) a B chain modified by a C-terminal diol element such that one hydroxyl group substitutes for the C-terminal carboxylate function in combination with (b) a glucose-binding element attached to the A chain at or near its N terminus. Compositions comprising such insulin analogs are used in methods of treating a patient with diabetes mellitus.
Claims20
An insulin analogue consisting of an A chain modified by a glucose-binding element at or near its N terminus and a variant B chain comprising a diol group at the C terminus of the B chain such that the polypeptide chain ends with a hydroxyl group rather than with a carboxylate group.
Dependencies are inferred from the claim text.